Chimeric HDAC and the Cytoskeleton Inhibitor Broxbam as a Novel Therapeutic Strategy for Liver Cancer

0
316
The potential suitability of broxbam for the treatment of liver cancer was investigated.
[International Journal of Oncology]
Abstract